durvalumab
astrazeneca
['durvalumab', 'nsclc', 'lung', 'radio', 'sclc']
outcomes with #durvalumab #icp after chemoradiotherapy in stage iiia-n2 non-small-cell lung cancer #nsclc #pacific trial #asco22 
The #OpenAccess journal of @myESMO dedicated to #oncology research